Pharmacologic Agents for Knee Articular Cartilage Injury and Disease

Houpt, Joseph B.; Pritzker, Kenneth P.H.; Gahunia, Harpal K.

doi:10.1007/978-1-4939-7587-7_9

Articular Cartilage of the Knee 2020

DOI: 10.1007/978-1-4939-7587-7_9

|View full text |Cite

Pharmacologic Agents for Knee Articular Cartilage Injury and Disease

Joseph B. Houpt

Kenneth P.H. Pritzker

Harpal K. Gahunia³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 99 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients

Bagheri-Hosseinabadi,

Moadab,

Abbasifard

2024

BMC Endocr Disord

View full text Add to dashboard Cite

Background Promoting prevalence of metabolic syndrome (MetS) in Rheumatoid arthritis (RA) patients might occur secondary to RA therapy as well as sedentary life style. However, conflicting observations have been reported on the correlation between MetS and RA. This study aimed to determine the frequency of MetS and association of its components in RA. Methods In this study, 500 RA patients and 500 age- and gender-matched healthy controls were enrolled. MetS was fulfilled through the International Diabetes Federation (IDF) criteria. A multivariate regression model was used to control for variables independently associated with the risk of MetS in RA patients. Results The prevalence of MetS was 58.8% on IDF criteria in RA patients that was higher than controls (20.4%). Higher incidence of cardiovascular disease (CVD), the familial history of CVD, hypertension, type 2 diabetes mellitus (T2DM), smoking, dyslipidemia, and higher levels of body mass index (BMI), waist circumference (WC), total cholesterol level, fasting blood sugar (FBS), triglyceride (TG) level, low-density lipoprotein (LDL) level, while lower levels of high-density lipoprotein (HDL) were associated with an increased risk of MetS in RA patients. Multivariate regression analysis indicated that age, WC, dyslipidemia, LDL, and DAS28 were independent predictors of MetS in the RA patients. Conclusions The prevalence of MetS is higher in RA patients. Our findings suggest an association between cardiovascular risk factors and the increased prevalence of MetS in RA patients.

show abstract

Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients

Bagheri-Hosseinabadi,

Moadab,

Abbasifard

2024

BMC Endocr Disord

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pharmacologic Agents for Knee Articular Cartilage Injury and Disease

Cited by 1 publication

References 99 publications

Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients

Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients

Contact Info

Product

Resources

About